Chemoinformaics analysis of D-10-Hydroxy-Palmitone
| Molecular Weight | 450.836 | nRot | 28 |
| Heavy Atom Molecular Weight | 388.34 | nRig | 1 |
| Exact Molecular Weight | 450.48 | nRing | 0 |
| Solubility: LogS | -7.516 | nHRing | 0 |
| Solubility: LogP | 12.57 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 94 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 62 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 93.9132 |
| nHD | 0 | BPOL | 63.0668 |
| QED | 0.108 |
| Synth | 1.699 |
| Natural Product Likeliness | 0.256 |
| NR-PPAR-gamma | 0.535 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -5.338 |
| MDCK | 0.00000327 |
| BBB | 0.002 |
| PPB | 0.986021 |
| VDSS | 3.615 |
| FU | 0.00633426 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.133 |
| CYP2c19-inh | 0.101 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.979 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.026 |
| CYP3a4-inh | 0.159 |
| CYP3a4-sub | 0.012 |
| CL | 4.675 |
| T12 | 0.033 |
| hERG | 0.598 |
| Ames | 0.005 |
| ROA | 0.01 |
| SkinSen | 0.965 |
| Carcinogencity | 0.017 |
| EI | 0.91 |
| Respiratory | 0.778 |
| NR-Aromatase | 0.064 |
| Antiviral | No |
| Prediction | 0.693067 |